Health Sciences Acquisitions Corporation 2 HSAQ

$ 10.45 -2.52%

Quarterly report 2024-Q3
added 11-12-2024

Health Sciences Acquisitions Corporation 2 Financial Statements 2011-2024 | HSAQ

Annual Financial Statements Health Sciences Acquisitions Corporation 2

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	347 M	159 M	202 M	189 M	-	-	-	-	-	-	-	-	-
Shares	33.2 M	15 M	20.4 M	16 M	-	-	-	-	-	-	-	-	-
Historical Prices	10.4	10.6	9.86	11.8	-	-	-	-	-	-	-	-	-
Net Income	-49.1 M	-33.6 M	-379 K	-174 K	-	-	-	-	-	-	-	-	-
Revenue	2.76 M	3.53 M	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	186 K	211 K	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-51.5 M	-32.7 M	-395 K	-	-	-	-	-	-	-	-	-	-
Interest Expense	3.85 M	50 K	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-51.2 M	-32.4 M	-395 K	-174 K	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	180 K	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	20.3 M	14 M	275 K	130 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Health Sciences Acquisitions Corporation 2

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	37.6 M	35.8 M	35.8 M	35.8 M	35.2 M	34.6 M	27.6 M	20.2 M	20.2 M	10.1 M	9.23 M	4.45 M	20.4 M	20.4 M	20.4 M	4.45 M	13.8 M	5.31 M	5.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-15.4 M	-16 M	-13.5 M	-	-13.3 M	-12 M	-10.9 M	-	-10.3 M	-7.85 M	-5.73 M	-	-90.4 K	-92.3 K	-108 K	-	-66.2 K	-15.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	987 K	778 K	620 K	-	419 K	915 K	1.16 M	-	1.16 M	401 K	866 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	68 K	44 K	34 K	-	41 K	54 K	44 K	-	56 K	60 K	42 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-16.3 M	-16.9 M	-14.4 M	-	-14.5 M	-13 M	-11.5 M	-	-10.1 M	-7.63 M	-5.13 M	-	-94.4 K	-96.3 K	-112 K	-	-68.6 K	-15.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	902 K	-11 K	-	915 K	941 K	885 K	-	63 K	-246 K	236 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-16.3 M	-16.8 M	-14.3 M	-	-14.5 M	-12.9 M	-11.5 M	-	-10 M	-7.58 M	-5.08 M	-	-94.4 K	-96.3 K	-112 K	-	-68.6 K	-15.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	112 K	-	68.6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	5.67 M	6.47 M	5.9 M	-	6.34 M	5.32 M	4.41 M	-	5.28 M	2.95 M	2.48 M	-	64.4 K	66.3 K	30 K	-	68.6 K	15.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency